FASN and breast cancer: Studies from our laboratory and others revealed that a subgroup of patients with breast cancer exhibit aberrant fatty acid production mediated by activation of the fatty acid (FA) synthase (FASN) enzyme, even in the presence of abundant extracellular FAs, strongly suggesting an inherent dependency of more virulent tumors on FASN signaling [21,22,23,24,25].